Merus: Summarizing The Voting Results At The Company S Annual General Meeting Of Shareholders Held On May 7, 2024 (the Annual Meeting ). This Amendment Is For The Purpose Of Correcting The Number Of Abstentions Reported For Proposal 2, Which Was Reported Incorrectly In The Original Report Due To A Typographical Error. Accordingly, This Amendment No. 1 Should Be Read In Conjunction With The Original Report

Show full article

This functionality is available for registred users only

• Full name
  Merus N.V.
• Registration country
  Netherlands
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***